Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04979442
Title Treatment of Milademetan Versus Trabectedin in Patient With Dedifferentiated Liposarcoma (MANTRA) (MANTRA)
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Rain Therapeutics Inc.
Indications

well-differentiated liposarcoma

dedifferentiated liposarcoma

Therapies

Trabectedin

Milademetan Tosylate

Age Groups: senior | adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUT


No variant requirements are available.